
Sign up to save your podcasts
Or


In a podcast conversation with Pharm Exec, Ken Banta, founder and CEO of The Vanguard Network, and Andrew Hall, CEO of Consano Bio, discuss what effective leadership looks like in today’s volatile capital and regulatory climates for emerging biotechs. Part 1 of the conversation explores why Banta and Hall believe CEOs of these companies must act as stabilizers and translators—balancing risk with opportunity and turning complex scientific innovation into clear strategy for investors, regulators, and employees alike.
Highlights of the discussion include:
By Pharmaceutical Executive Podcast4.9
1414 ratings
In a podcast conversation with Pharm Exec, Ken Banta, founder and CEO of The Vanguard Network, and Andrew Hall, CEO of Consano Bio, discuss what effective leadership looks like in today’s volatile capital and regulatory climates for emerging biotechs. Part 1 of the conversation explores why Banta and Hall believe CEOs of these companies must act as stabilizers and translators—balancing risk with opportunity and turning complex scientific innovation into clear strategy for investors, regulators, and employees alike.
Highlights of the discussion include:

30,678 Listeners

4,173 Listeners

3,229 Listeners

1,724 Listeners

4,392 Listeners

429 Listeners

1,650 Listeners

183 Listeners

1,447 Listeners

9,565 Listeners

337 Listeners

1,315 Listeners

6,119 Listeners

85 Listeners

148 Listeners